Sentinel lymph node positivity and overall survival in immunosuppressed patients with Merkel cell carcinoma: a national cohort study

2020 ◽  
Vol 183 (3) ◽  
pp. 569-571
Author(s):  
Y. Song ◽  
C. Zheng ◽  
A.B. Shannon ◽  
D.L. Fraker ◽  
J.T. Miura ◽  
...  
Keyword(s):  
Overall Survival ◽  
Cohort Study ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Merkel Cell ◽  
National Cohort ◽  
Immunosuppressed Patients ◽  
Sentinel Lymph Node Positivity

A Case of Nasal Merkel Cell Carcinoma Draining to a Buccinator Sentinel Lymph Node

2016 ◽  
Vol 41 (11) ◽  
pp. e480-e481 ◽  
Author(s):  
Mohammed S. Bermo ◽  
Alan Leung ◽  
Fatemeh Behnia
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Merkel Cell

scholarly journals Role of Sentinel Lymph Node Biopsy in the Management of Merkel Cell Carcinoma

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Eric P. Arruda ◽  
Kevin M. Higgins
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Neck Region ◽  
Lymph Node Biopsy ◽  
Merkel Cell ◽  
Treatment Protocols ◽  
Node Biopsy

Merkel cell carcinoma (MCC) is a rare and typically aggressive form of skin cancer. It most commonly affects the elderly and has a predilection for the sun-exposed skin of the head and neck region. Other etiological factors include immune suppression, organ transplantation, and polyoma virus infection. MCC has a propensity to spread to regional lymphatics with a high locoregional recurrence rate. Since its discovery in 1972, treatment paradigms have shifted, with no consensus on optimal management strategies. Currently, standard of care includes surgical intervention to the primary and locoregional site with adjuvant radiotherapy for high-risk disease. In this paper, we discuss the history, pathology, and epidemiology of this rare disease with a focus on the evidentiary basis of treatment protocols. The use of sentinel lymph node biopsy as a management option will be the focus of this paper.

Who Receives Standard of Care: Factors Influencing the Use of Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma

2020 ◽  
Vol 231 (4) ◽  
pp. S286
Author(s):  
Michael J. Minarich ◽  
Elizabeth A. Handorf ◽  
Leah G. Stockton ◽  
Maitham A. Moslim ◽  
Stephanie H. Greco ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Standard Of Care ◽  
Lymph Node Biopsy ◽  
Merkel Cell ◽  
Factors Influencing ◽  
Node Biopsy
Sign in / Sign up

Export Citation Format

Share Document